C

퀀타매트릭스

317690KOSDAQ

50.0 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 15.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Quantametrics is a company specializing in the development, production, and sale of in-vitro diagnostics (IVD) medical devices, focusing on early diagnosis and prognosis prediction for sepsis and antimicrobial susceptibility testing (AST). The company leverages innovative technologies such as microfluidic chips and agarose gel to provide high-sensitivity and high-accuracy diagnostic solutions to hospitals and testing institutions.

Number of Employees

103people

Average Salary

54.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
1.21Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
-83.64Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
3.50Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲13.9% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲15.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -107.2% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 2,405Won52-week high 5,18052-week low 1,988
1-month return6.0Point

1m +15.90% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral주주총회소집공고2026-08-31
  • Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-08-28
  • Neutral반기보고서 (2026.06)2026-08-14